Drug therapy in elderly heart failure patients.
Comorbidities
Elderly
Heart failure
Multidisciplinary care
Pharmacotherapy
Journal
European heart journal supplements : journal of the European Society of Cardiology
ISSN: 1520-765X
Titre abrégé: Eur Heart J Suppl
Pays: England
ID NLM: 100886647
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
31
12
2019
pubmed:
31
12
2019
medline:
31
12
2019
Statut:
ppublish
Résumé
Although heart failure (HF) is considered as a cardiogeriatric syndrome, elderly and very elderly patients are under-represented in the vast majority of clinical trials investigating novel drugs and therapies in this population. The homoeostatic systems of elderly subjects are very fragile, and the management of HF accompanied by numerous comorbidities requires a holistic approach towards the patient, with special emphasis not only on psychosomatic problems but also on the individual (including social) needs of each particular patient, along with the support for the family and/or caregivers. In this article, we summarize current evidence regarding pharmacotherapy of elderly patients with HF and summarize the clinical problems occurring in this population.
Identifiants
pubmed: 31885505
doi: 10.1093/eurheartj/suz237
pii: suz237
pmc: PMC6926409
doi:
Types de publication
Journal Article
Langues
eng
Pagination
L8-L11Informations de copyright
Published on behalf of the European Society of Cardiology. © The Author(s) 2019.
Références
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):78-88
pubmed: 27897406
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):907-914
pubmed: 28913934
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):607-614
pubmed: 28597612
Eur J Heart Fail. 2018 Sep;20(9):1315-1322
pubmed: 29806165
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):834-843
pubmed: 30109778
Eur Heart J. 2015 Oct 7;36(38):2576-84
pubmed: 26231885
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):3-19
pubmed: 29151281
Eur J Heart Fail. 2017 Aug;19(8):974-986
pubmed: 28401618
Eur Heart J Cardiovasc Pharmacother. 2018 Jan 1;4(1):54-63
pubmed: 28633477
J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):349-369
pubmed: 28432755
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182
pubmed: 28329228
Eur J Heart Fail. 2017 Apr;19(4):540-548
pubmed: 28025867
Eur Heart J. 2005 Feb;26(3):215-25
pubmed: 15642700
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):3-11
pubmed: 29490032
Eur J Heart Fail. 2018 Feb;20(2):216-227
pubmed: 29148148
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Am Heart J. 2002 Mar;143(3):412-7
pubmed: 11868045
Eur J Heart Fail. 2017 Dec;19(12):1586-1596
pubmed: 28295985
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):229-237
pubmed: 27897431
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):549-556
pubmed: 28244261
Eur J Heart Fail. 2011 Jun;13(6):670-80
pubmed: 21429992
Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):138-141
pubmed: 29319788
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):251-258
pubmed: 27896949
Am Heart J. 2003 Aug;146(2):250-7
pubmed: 12891192
J Card Fail. 2010 Jun;16(6):e1-194
pubmed: 20610207
Eur J Heart Fail. 2017 Nov;19(11):1414-1423
pubmed: 28463464
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):198-213
pubmed: 28329196
Card Fail Rev. 2017 Nov;3(2):102-107
pubmed: 29387461
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):523-526
pubmed: 28452130
Heart. 2007 Sep;93(9):1137-46
pubmed: 17699180
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):172-179
pubmed: 29309557
Expert Opin Pharmacother. 2017 May;18(7):645-655
pubmed: 28375036
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):547-556
pubmed: 29573220
Heart Fail Rev. 2017 Mar;22(2):219-228
pubmed: 28164253
Card Fail Rev. 2017 Apr;3(1):46-51
pubmed: 28785475
Eur J Heart Fail. 2018 Aug;20(8):1191-1201
pubmed: 29663586
Eur J Heart Fail. 2018 Jan;20(1):55-62
pubmed: 28967680
Herz. 2018 May;43(3):207-213
pubmed: 29340718
Can J Cardiol. 2017 Oct;33(10):1237-1244
pubmed: 28807523